KOASTAL-1 Study

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Emergent’s Q2 adjusted EBITDA hit $96.5m, so what does its CFO successor inherit?

Rath AG nearly erased its first-half loss. Why is it now closing two European factories?

Pernod Ricard reports 19% organic sales growth in India despite a 10% decline in the United States and a 25% slump in China, highlighting the growing importance of India’s premium spirits market as the French drinks group explores a potential Indian IPO and navigates shifting global demand. Representative image.

Pernod Ricard India sales jump 19% as U.S. falls 10% and China drops 25%

Ahold Delhaize faces disruptions to online grocery services and supermarket distribution following a cybersecurity incident affecting operations across Europe and the United States, raising concerns about digital retail resilience, potential revenue losses and the recovery of its e-commerce platforms. Representative image.

Ahold Delhaize cyber outage keeps grocery e-commerce offline as AD shares recover

Neumora Therapeutics’ KOASTAL-1 study of navacaprant for MDD falls short on primary endpoint

Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company specialising in neuroscience, has announced results from the KOASTAL-1…

μFR system
αvβ6-integrin
α4β7 integrin
Þorgerður Katrín Gunnarsdóttir
Zywie Ventures
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynyz
ZYNRELEF

January 2, 2025